logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Onychomycosis

    FiltersReset Filters
    5 results

    • ciclopirox

      (ciclopirox)
      Encube Ethicals Private Limited
      Usage: Ciclopirox topical solution, 8% (nail lacquer), is indicated for treating mild to moderate onychomycosis of fingernails and toenails in immunocompetent patients. It should be part of a comprehensive management program, including nail removal by a qualified healthcare professional, and is not recommended for use with systemic antifungal agents.

    • jublia

      (efinaconazole)
      Bausch Health US LLC
      Usage: JUBLIA (efinaconazole) topical solution, 10% is indicated for the topical treatment of onychomycosis of the toenails caused by Trichophyton rubrum and Trichophyton mentagrophytes.

    • tavaborole

      (TAVABOROLE topical solution, 5%)
      Encube Ethicals Private Limited
      Usage: Tavaborole topical solution, 5% is indicated for the treatment of onychomycosis of the toenails caused by Trichophyton rubrum or Trichophyton mentagrophytes.

    • terbinafine

      (Terbinafine Hydrochloride)
      Aurobindo Pharma Limited
      Usage: Terbinafine tablets are indicated for treating onychomycosis (nail fungal infections) of the toenail or fingernail caused by dermatophytes. Diagnosis should be confirmed through appropriate lab testing prior to treatment.

    • terbinafine

      (Terbinafine)
      Chartwell RX, LLC
      Usage: Terbinafine tablets are indicated for treating onychomycosis of toenails or fingernails caused by dermatophytes. Diagnosis must be confirmed through laboratory testing, such as KOH preparation, fungal culture, or nail biopsy, prior to starting treatment.